Valerio Therapeutics Stock Quote ALVIO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.0798

Bid

0.075

Ask

0.08

Volume

191,805

0.074 Day's Range 0.08

0.065 52 Week Range 0.166

Market Cap

12.318M

Previous Close

0.075

Open

0.0749

Last Trade

450

0.0798

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

53,965

Shares Outstanding

154,364,273

Dividend Yield

PE Ratio

-9.71

Earnings Per Share (EPS)

-0.13

Revenue

4.45M

Net Profit

-20.34M

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Website

valeriotx.com/

Headquarters

Paris, Paris, Fra

Founded

Valerio Therapeutics is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0.08 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0.065 € to 0.166 €.

Valerio Therapeutics currently has 154,364,273 shares outstanding. The market capitalization of Valerio Therapeutics is 11.58 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.71.

Réunion du Conseil d'administration de Valerio Therapeutics S.A. du 13 novembre 2024

Regulatory News: Lors d’une réunion tenue le 13 novembre 2024, le Conseil d'administration de Valerio Therapeutics (“Valerio Therapeutics” or la “Société”) (Euronext Growth Paris : ALVIO) a...

Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company

Valerio Therapeutics acquires Emglev Therapeutics, a single-domain antibody-based therapeutics company The transaction was completed on September 29, 2024, enabling the acquisition of Emglev’s...

Half-Year Liquidity Contract Statement for Valerio Therapeutics

Regulatory News: Under the liquidity contract entered into between VALERIO THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30...

Valerio Therapeutics : compte rendu de l’assemblée générale mixte du 4 juin 2024

Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le...

Valerio Therapeutics fait une mise à jour du développement clinique de son essai clinique de phase 1/2 VIO-01

Le premier niveau de dose, évaluant 3 patients de l'essai VIO-01-101, a été autorisé conformément aux recommandations du Comité d'examen clinique. Aucun événement indésirable cliniquement...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0086	12.0786516854	0.0712	0.08	0.0712	85674	0.07140838	DE
4	0.0078	10.8333333333	0.072	0.082	0.07	83074	0.07439089	DE
12	-0.0036	-4.31654676259	0.0834	0.0876	0.07	53965	0.07740926	DE
26	-0.0204	-20.3592814371	0.1002	0.12	0.065	75997	0.08808149	DE
52	-0.0822	-50.7407407407	0.162	0.166	0.065	86106	0.10588142	DE
156	-0.1932	-70.7692307692	0.273	0.348	0.065	80901	0.15155915	DE
260	-0.1932	-70.7692307692	0.273	0.348	0.065	80901	0.15155915	DE

ALVIO - Frequently Asked Questions (FAQ)

What is the current Valerio Therapeutics share price?

The current share price of Valerio Therapeutics is 0.0798 €

How many Valerio Therapeutics shares are in issue?

Valerio Therapeutics has 154,364,273 shares in issue

What is the market cap of Valerio Therapeutics?

The market capitalisation of Valerio Therapeutics is EUR 11.58M

What is the 1 year trading range for Valerio Therapeutics share price?

Valerio Therapeutics has traded in the range of 0.065 € to 0.166 € during the past year

What is the PE ratio of Valerio Therapeutics?

The price to earnings ratio of Valerio Therapeutics is -9.71

What is the cash to sales ratio of Valerio Therapeutics?

The cash to sales ratio of Valerio Therapeutics is 44.44

What is the reporting currency for Valerio Therapeutics?

Valerio Therapeutics reports financial results in EUR

What is the latest annual turnover for Valerio Therapeutics?

The latest annual turnover of Valerio Therapeutics is EUR 4.45M

What is the latest annual profit for Valerio Therapeutics?

The latest annual profit of Valerio Therapeutics is EUR -20.34M

What is the registered address of Valerio Therapeutics?

The registered address for Valerio Therapeutics is 49 BOULEVARD DU GENERAL MARTIAL VALIN, PARIS, PARIS, 75015

What is the Valerio Therapeutics website address?

The website address for Valerio Therapeutics is valeriotx.com/

Which industry sector does Valerio Therapeutics operate in?

Valerio Therapeutics operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DMSBSDiagnostic Medical Systems	0.0075 € (150.00%)	1,000
ALAGOEPango SA	0.216 € (93.55%)	13.2M
MLSMLSmalto	0.019 € (52.00%)	33.89k
MLAAHAmatheon Agri Holding NV	0.03 € (50.00%)	3.45k
CFNCofina SGPS SA	26.90 € (37.95%)	4.6k
SEQUASequana medical NV	2.45 € (-19.93%)	890.68k
FIPPFipp	0.116 € (-17.73%)	1,000
ECTotalEnergies EP Gabon	168.50 € (-16.58%)	30.47k
MLEFAEduformAction	0.402 € (-16.25%)	1.1k
EIFDSTour Eiffel DS	0.0052 € (-13.33%)	50.44k
ATOAtos SE	0.0025 € (-3.85%)	1.49B
BCPBanco Comercial Portugues SA	0.4589 € (-1.25%)	96.8M
ALVERVergnet	0.002 € (0.00%)	34.56M
ALCYBCybergun	0.0001 € (0.00%)	31.17M
ALHPIHopium SA	0.0049 € (4.26%)	29.02M